Evidence map›Paper›PMID 24849663›Full record

ArticleJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2014

Neuroprotection after traumatic brain injury in heat-acclimated mice involves induced neurogenesis and activation of angiotensin receptor type 2 signaling.

Gali Umschweif, Dalia Shabashov, Alexander G Alexandrovich, Victoria Trembovler, Michal Horowitz, Esther Shohami

Open access · bronzeAbstract read
In one paragraph

Article in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. The Renin Angiotensin System as a Therapeutic Target in Traumatic Brain Injury.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2023
    Review
  7. The Angiotensin ATPharmacological reviews · 2022
    Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. The Role of BDNF in Experimental and Clinical Traumatic Brain Injury.International journal of molecular sciences · 2021
    Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Gali Umschweif1] Department of Pharmacology, School of Pharmacy, Institute of Drug Research, Jerusalem, Israel [2] Laboratory of Environmental Physiology, The Hebrew University of Jerusalem, Jerusalem, Israel.
Dalia ShabashovDepartment of Pharmacology, School of Pharmacy, Institute of Drug Research, Jerusalem, Israel.
Alexander G AlexandrovichDepartment of Pharmacology, School of Pharmacy, Institute of Drug Research, Jerusalem, Israel.
Victoria TrembovlerDepartment of Pharmacology, School of Pharmacy, Institute of Drug Research, Jerusalem, Israel.
Michal HorowitzLaboratory of Environmental Physiology, The Hebrew University of Jerusalem, Jerusalem, Israel.
Esther ShohamiDepartment of Pharmacology, School of Pharmacy, Institute of Drug Research, Jerusalem, Israel.
Hebrew University of Jerusalem · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Long-term exposure of mice to mild heat (34°C±1°C) confers neuroprotection against traumatic brain injury (TBI); however, the underling mechanisms are not fully understood. Heat acclimation (HA) increases hypothalamic angiotensin II receptor type 2 (AT2) expression and hypothalamic neurogenesis. Accumulating data suggest that activation of the brain AT2 receptor confers protection against several types of brain pathologies, including ischemia, a hallmark of the secondary injury occurring following TBI. As AT2 activates the same pro-survival pathways involved in HA-mediated neuroprotection (e.g., Akt phosphorylation, hypoxia-inducible factor 1α (HIF-1α), and brain-derived neurotrophic factor (BDNF)), we examined the role of AT2 in HA-mediated neuroprotection after TBI. Using an AT2-specific antagonist PD123319, we found that the improvements in motor and cognitive recovery as well as reduced lesion volume and neurogenesis seen in HA mice were all diminished by AT2 inhibition, whereas no significant alternations were observed in control mice. We also found that nerve growth factor/tropomyosin-related kinase receptor A (TrkA), BDNF/TrkB, and HIF-1α pathways are upregulated by HA and inhibited on PD123319 administration, suggesting that these pathways play a role in AT2 signaling in HA mice. In conclusion, AT2 is involved in HA-mediated neuroprotection, and AT2 activation may be protective and should be considered a novel drug target in the treatment of TBI patients.

Indexed as

AcclimatizationHot TemperatureNeurogenesisAngiotensin II Type 2 Receptor BlockersAnimalsBehavior, AnimalBrain InjuriesDisease Models, AnimalHead Injuries, ClosedImidazolesMaleMiceMice, Inbred StrainsMotor ActivityPyridinesReceptor, Angiotensin, Type 2Angiotensin II Type 2 Receptor BlockersImidazolesPD 123319PyridinesReceptor, Angiotensin, Type 2

Identifiers

PMID24849663
PMCPMC4126099
OpenAlexW2032782933

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.